loading

Cocrystal Pharma Inc Stock (COCP) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
10.89%
4.158
4.666 4.443 4.339 5.111
Depreciation and Amortization
12.50%
0.035
0.04 0.053 0.047 0.049
Operating Income/Loss
10.89%
-4.158
-4.666 -4.443 -4.339 -5.111
Nonoperating Income/Loss
0.00%
0.202
0.202 0.278 - -0.078
Income/Loss From Continuing Operations Before Tax
11.38%
-3.956
-4.464 -4.165 -4.166 -5.189
Income/Loss From Continuing Operations After Tax
11.38%
-3.956
-4.464 -4.165 -4.166 -5.189
Net Income/Loss
11.38%
-3.956
-4.464 -4.165 -4.166 -5.189
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,255%
10.17
0.19 10.15 10.06 8.143
Diluted Average Shares
5,255%
10.17
0.19 10.15 10.06 -0.956
Basic Earnings Per Share
11.36%
-0.39
-0.44 -0.41 -0.41 -0.64
Diluted Earnings Per Share
11.36%
-0.39
-0.44 -0.41 -0.41 -0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):